Relievant Medsystems Closes $70 Million Financing to Accelerate U.S. Launch of Intracept Procedure

Relievant Medsystems Intracept Procedure

Relievant Medsystems completed a $70 million equity financing. The funds build on commercial momentum following publication of 5-year data demonstrating long term clinical benefits of the Intracept procedure in chronic low back pain (CLBP) patients.

Intracept Intraosseous Nerve Ablation uses radiofrequency energy to ablate...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us